Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial

Peer Review reports

Original Submission
15 Dec 2023	Submitted	Original manuscript
21 Mar 2024	Reviewed	Reviewer Report - Yang Chen
27 Mar 2024	Reviewed	Reviewer Report - Sara Ghazizadeh
27 Mar 2024	Reviewed	Reviewer Report - harsh Kishore
29 Mar 2024	Reviewed	Reviewer Report - Singal AK
31 Mar 2024	Reviewed	Reviewer Report - Chamila Dalpatadu
31 Mar 2024	Reviewed	Reviewer Report - Alexandra Gorelik
1 Apr 2024	Reviewed	Reviewer Report - Theodore Feldman
16 May 2024	Author responded	Author comments - Norbert Stefan
Resubmission - Version 2
16 May 2024	Submitted	Manuscript version 2
18 May 2024	Reviewed	Reviewer Report - Yang Chen
21 May 2024	Reviewed	Reviewer Report - Singal AK
21 May 2024	Reviewed	Reviewer Report - Chamila Dalpatadu
21 May 2024	Reviewed	Reviewer Report - harsh Kishore
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
29 May 2024	Editorially accepted
11 Jun 2024	Article published	10.1186/s13063-024-08208-4

Back to article page